Erol Harvey to present at MicroTAS
Understanding the pathways from the laboratory to real world products
During exciting times of great change and opportunity in lab-on-a-chip enabled healthcare, the pathway to commercialization is crowded with new technologies. It is important to guide travellers through the many risks, technical, financial and regulatory, from laboratory to real world products suitable for the marketplace.
To optimize the chances of successfully reaching the journey's end, you need to clearly define where you're going. Understanding user requirements, adopting a design-for-manufacture approach and having a clear idea of your end-goal can eliminate the many dangers and help avoid the funding 'valley of death'.
Though product development need not be a long journey, it won't be achieved in one giant step. Implementing a staged development strategy segments the pathway into manageable, investible and technically achievable stages, concentrating on risk-based developments as opposed to an agile one. Introducing verification and validation at each stage ensures confidence for your investors, and your product's commercial viability.
Don't miss out on what's sure to be a great event.
The 18th International Conference on Miniaturized Systems for Chemistry and Life Sciences (MicroTAS) is a premier forum for reporting research results in microfluidics, microfabrication, nanotechnology, integration, materials and surfaces, analysis and synthesis, and detection technologies for life science and chemistry.
Wednesday, 29 October 2014 16:00 - 17:00
Industrial Stage Gallery, Street level, behind registration
Find out more about the Industrial Stage Presentations here.
26 - 30 October 2014 Booth #51
Henry B. Gonzalez Convention Center, San Antonio, TX
Find out more about MicroTAS here.